BGT-002

· Burgeon Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BGT-002, covering 2024-07-09 to 2024-07-09. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of BGT-002 Tablets in Subjects With Nonalcoholic Steatohepatitis [Phase 1, Phase 2]